Nested high-resolution melting curve analysis a highly sensitive, reliable, and simple method for detection of JAK2 exon 12 mutations--clinical relevance in the monitoring of polycythemia.

[1]  V. Ugo,et al.  Interlaboratory Development and Validation of a HRM Method Applied to the Detection of JAK2 Exon 12 Mutations in Polycythemia Vera Patients , 2010, PloS one.

[2]  F. Rodeghiero,et al.  Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: Report of a new mutation , 2009, American journal of hematology.

[3]  T. Haferlach,et al.  Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera , 2009, Haematologica.

[4]  I. Rapado,et al.  High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms. , 2009, The Journal of molecular diagnostics : JMD.

[5]  A. Green,et al.  Rapid identification of JAK2 exon 12 mutations using high resolution melting analysis , 2008, Haematologica.

[6]  R. Kralovics,et al.  Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations. , 2008, Blood.

[7]  J. Gécz,et al.  Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients , 2008, Leukemia.

[8]  M. Cazzola,et al.  Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. , 2008, Blood.

[9]  M. Cazzola.  Somatic mutations of JAK2 exon 12 as a molecular basis of erythrocytosis , 2007, Haematologica.

[10]  B. Bellosillo,et al.  JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis , 2007, Haematologica.

[11]  A. Green,et al.  The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels , 2007, Haematologica.

[12]  A. Green,et al.  Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera , 2007, British journal of haematology.

[13]  A. Tefferi,et al.  Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera , 2007, Leukemia.

[14]  M. Stratton,et al.  JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. , 2007, The New England journal of medicine.

[15]  François Girodon,et al.  The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera. , 2006, Blood.

[16]  C. Wittwer,et al.  Quantitative heteroduplex analysis for single nucleotide polymorphism genotyping. , 2005, Analytical biochemistry.

[17]  Stefan N. Constantinescu,et al.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera , 2005, Nature.

[18]  Mario Cazzola,et al.  A gain-of-function mutation of JAK2 in myeloproliferative disorders. , 2005, The New England journal of medicine.

[19]  Sandra A. Moore,et al.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.

[20]  P. Campbell,et al.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.

[21]  松山 智洋.  What's going on 造血器腫瘍 A gain-of-function mutation of JAK2 in myeloproliferative disorders. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, Tichelli A, Cazzola M, Skoda RC. N Engl J Med. 2005; 352: 1779-90. PMID:15858187.--慢性骨髄増殖性疾患においてJAK2遺伝子の変異が高頻度にみられることを示した論文 , 2005 .